# Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2

> **NCT01837693** · NA · COMPLETED · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 41127 (actual)

## Conditions studied

- Precancerous Conditions
- Neoplasms

## Interventions

- **PROCEDURE:** Experimental: immediate colposcopy

## Key facts

- **NCT ID:** NCT01837693
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-01
- **Primary completion:** 2017-01-01
- **Final completion:** 2017-01-01
- **Target enrollment:** 41127 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01837693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01837693, "Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01837693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*